C2N Diagnostics Competitors and Similar CompaniesClear all
C2N Diagnostics's competitors and similar companies include ZZ Biotech, Alector and Crossbeta Biosciences.
 C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. |  ZZ Biotech ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Crossbeta Biosciences Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas. | |
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 2013 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations St. Louis, US HQ | Locations Houston, US HQ Sydney, AU | Locations San Francisco, US HQ | Locations Utrecht, NL HQ Utrecht, NL |
Employees | Employees 96 | Employees 6810% increase | Employees 2382% decrease | Employees 2 |
Funding | ||||
Latest funding round | Latest funding round $ 20m (about 6 years ago) | Latest funding round $ 6.9m (over 11 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 20m | Total funding raised $ 7.9m | Total funding raised $ 194.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZZ Biotech
HQ
Houston, US
Employees
68↑ 10% increase
ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyCrossbeta Biosciences
HQ
Utrecht, NL
Employees
2
Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas.
View company